| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |